Kanvas Biosciences: Funding, Investors & Team (Oct 2026)
Kanvas Biosciences has created advanced imaging technology for identifying microbes, offering unparalleled speed, range, and flexibility. The company is dedicated to revolutionizing microbial research and infectious disease diagnostics with their cutting-edge imaging technology.
Kanvas Biosciences has raised $76.4M across 4 funding rounds on record, the most recent a Series A of $48.0M announced in May 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kanvas Biosciences Company Profile and Key Stats
Latest funding round on record: May 2026.
Kanvas Biosciences Funding Rounds
Kanvas Biosciences raised $12.0M in a Seed announced in Jun 2023.
9 months later, an undisclosed round of $3.9M was announced in Mar 2024.
4 months later, a Series A of $12.5M was announced in Jul 2024.
1.8 years later, a Series A of $48.0M was announced in May 2026.
Kanvas Biosciences Founders and Leadership Team
Contact details for the Kanvas Biosciences team: 1 of 2 have an email address on file.
Start 14-day free trial →Kanvas Biosciences Funding Compared to Other Biotechnology Startups
Kanvas Biosciences' latest round of $48.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kanvas Biosciences in Biotechnology and Monmouth Junction
Companies Similar to Kanvas Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Kanvas Biosciences Funding FAQs
What does Kanvas Biosciences do?
Kanvas Biosciences has created advanced imaging technology for identifying microbes, offering unparalleled speed, range, and flexibility. The company is dedicated to revolutionizing microbial research and infectious disease diagnostics with their cutting-edge imaging technology.
How much funding has Kanvas Biosciences raised?
Kanvas Biosciences has raised $76.4M across 4 rounds on record. The most recent is a Series A of $48.0M announced in May 2026.
When did Kanvas Biosciences last raise funding?
Kanvas Biosciences' most recent funding round on record is a Series A of $48.0M, announced in May 2026.
Who founded Kanvas Biosciences?
FundedIQ lists Hao Shi (Founder), Matthew Cheng (Founder) at Kanvas Biosciences.
Where is Kanvas Biosciences headquartered?
Kanvas Biosciences is based in Monmouth Junction, New Jersey, United States.
How many employees does Kanvas Biosciences have?
Kanvas Biosciences is in the 1-10 employee band.
How does Kanvas Biosciences' funding compare to other Biotechnology startups?
Kanvas Biosciences' latest round of $48.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Kanvas Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kanvas Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.